RxDoctor Payments DataLook up a doctor →

Amanda Adcock

Nurse Practitioner · Cullman, ALNPI 1730579889

Payments from drug & device makers

$8,847in general payments, 2019–2025

Across 516 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$535
  • Eisai Inc.$482
  • UCB, Inc.$474
  • Sunovion Pharmaceuticals Inc.$389
  • AstraZeneca$387
  • plus $5K from 49 others

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)99$1,394
Lilly USA, LLC34$535
Eisai Inc.22$482
UCB, Inc.48$474
Sunovion Pharmaceuticals Inc.29$389
AstraZeneca(2 entities)16$387
Neurocrine Biosciences, Inc.16$383
SK Life Science, Inc.21$356
Biogen19$329
Supernus Pharmaceuticals, Inc.17$329
Acorda Therapeutics, Inc22$319
Lundbeck LLC11$245
Neurelis, Inc.14$237
Avanir Pharmaceuticals, Inc.12$232
Argenx US, Inc.7$187
Axsome Therapeutics, Inc.10$180
Jazz Pharmaceuticals Inc.8$176
Pfizer10$166
Amgen9$165
Teva Pharmaceuticals USA, Inc.10$163
Otsuka America Pharmaceutical, Inc.7$155
Catalyst Pharmaceuticals, Inc.5$131
Harmony Biosciences LLC3$128
GE HealthCare6$128
Merz Pharmaceuticals, LLC4$113
Acadia Pharmaceuticals Inc5$109
Grifols USA, LLC4$89
Biohaven Pharmaceutical Holding Company Ltd.5$87
Biohaven Pharmaceuticals, Inc.3$74
Amneal Pharmaceuticals LLC4$61
Avion Pharmaceuticals4$59
Cycle Pharmaceuticals Inc3$58
Currax Pharmaceuticals LLC4$54
Alnylam Pharmaceuticals Inc.2$46
Avadel CNS Pharmaceuticals, LLC2$39
Kyowa Kirin, Inc.2$33
Mylan Specialty L.p.1$26
Sumitomo Pharma America, Inc.1$24
Merck1$22
Genentech USA, Inc.1$22
TG Therapeutics, Inc.1$21
Sanofi1$21
Corium, LLC1$20
EMD Serono, Inc.1$20
Paratek Pharmaceuticals, Inc.1$19
Radius Health, Inc.1$19
Daiichi Sankyo Inc.1$19
Johnson & Johnson1$18
Philips North America LLC1$18
Esperion Therapeutics, Inc.1$16
MDD US Operations, LLC1$16
Arbor Pharmaceuticals, Inc.1$16
Adamas Pharmaceuticals, Inc.1$15
Takeda Pharmaceuticals U.S.A., Inc.1$13
Novartis1$12

How this compares

$8,847 in reported general payments places this provider in the 95th percentile of 1,505 nurse practitioner providers in Alabama.

See all nurse practitioner providers in Alabama →

Medicare billing

Part B allowed, 2024
$3,463
Medicare patients
32
Services billed
46

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Cullman

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →